BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21937834)

  • 1. Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms.
    Kobayashi N; Hata N; Kume N; Shinada T; Tomita K; Shirakabe A; Kitamura M; Nozaki A; Inami T; Seino Y; Mizuno K
    Circ J; 2011; 75(12):2862-71. PubMed ID: 21937834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
    Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
    Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kita T
    Circ J; 2010 Jul; 74(7):1399-404. PubMed ID: 20467154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kominami G; Kita T
    J Cardiol; 2010 Sep; 56(2):159-65. PubMed ID: 20605699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome.
    Kobayashi N; Hata N; Kume N; Yokoyama S; Shinada T; Tomita K; Kitamura M; Shirakabe A; Inami T; Yamamoto M; Seino Y; Mizuno K
    Circ J; 2011; 75(12):2853-61. PubMed ID: 21963570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.
    Hayashida K; Kume N; Murase T; Minami M; Nakagawa D; Inada T; Tanaka M; Ueda A; Kominami G; Kambara H; Kimura T; Kita T
    Circulation; 2005 Aug; 112(6):812-8. PubMed ID: 16061745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
    Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T
    J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
    Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M
    J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of sLOX-1 Level in Acute Coronary Syndromes Based on Thrombolysis in Myocardial Infarction Risk Score and Clinical Outcome.
    Mashayekhi S; Ziaee M; Garjani A; Sarbakhsh P; Ghaffari S
    J Emerg Med; 2018 Sep; 55(3):390-398. PubMed ID: 30049431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay.
    Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G
    J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome.
    Kook H; Jang DH; Kim JH; Cho JY; Joo HJ; Cho SA; Park JH; Hong SJ; Yu CW; Lim DS
    Sci Rep; 2020 Nov; 10(1):20228. PubMed ID: 33214686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes.
    Çoner A; Aydınalp A; Müderrisoğlu H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):96-103. PubMed ID: 30961517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkers.
    Kobayashi N; Hata N; Kume N; Seino Y; Inami T; Yokoyama S; Shinada T; Tomita K; Kaneshige T; Mizuno K
    Circ J; 2011; 75(6):1433-9. PubMed ID: 21467660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expeditious exclusion of acute coronary syndrome diagnosis by combined measurements of copeptin, high-sensitivity troponin, and GRACE score.
    Bohyn E; Dubie E; Lebrun C; Jund J; Beaune G; Lesage P; Belle L; Savary D
    Am J Emerg Med; 2014 Apr; 32(4):293-6. PubMed ID: 24480311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 17. No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.
    Poldervaart JM; Röttger E; Dekker MS; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; van 't Hof AW; Mosterd A; Hoes AW
    PLoS One; 2015; 10(7):e0132000. PubMed ID: 26177390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of a high-sensitive troponin T assay and a troponin T point of care assay in the clinical routine of an Emergency Department: A clinical cohort study.
    Slagman A; von Recum J; Möckel M; Holert F; Meyer Zum Büschenfelde D; Müller C; Searle J
    Int J Cardiol; 2017 Mar; 230():454-460. PubMed ID: 28040285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of high sensitive troponin in non-ST elevation acute coronary syndrome.
    Velilla Moliner J; Gros Bañeres B; Povar Marco J; Santaló Bel M; Ordoñez Llanos J; Martín Martín A; Temboury Ruiz F
    Med Intensiva (Engl Ed); 2020 Mar; 44(2):88-95. PubMed ID: 30249382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and sLOX-1/oxidized LDL ratio as novel biomarkers of acute coronary syndrome.
    Hussein RA; Abdul-Rasheed OF; Basheer M
    Acta Biochim Pol; 2022 Apr; 69(2):309-314. PubMed ID: 35389578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.